Hidden switches in cell receptor proteins that control signaling
Emergent role of allostery on function of GPCRs and Trimeric G proteins
This project uses computer models and AI to reveal how small internal changes in receptor proteins affect cell signaling related to diabetes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beckman Research Institute/city of Hope NIH-funded |
| Lab location | 1 site (Duarte, United States) |
| Project ID | NIH-11266151 on NIH RePORTER |
What this research studies
From a patient's point of view, researchers are using large public protein structure databases, AI, and molecular simulations to watch how G protein-coupled receptors (GPCRs) and their partner G proteins move and communicate. They are focusing on a flexible internal piece called the third intracellular loop (ICL3) that may act like an internal switch to pick which signaling pathway turns on. By mapping these dynamic interactions they hope to pinpoint hidden binding sites and communication routes that static structures miss. The work is lab- and computer-based rather than a clinical treatment, but it aims to guide future drug designs for diabetes.
Who could benefit from this research
Good fit: This grant does not enroll patients—it's a computational and laboratory project—but people with diabetes could be future beneficiaries of drugs informed by the findings.
Not a fit: Patients seeking an immediate therapy or clinical trial enrollment should not expect direct benefit now, since the work is preclinical and not testing treatments in people.
Why it matters
Potential benefit: If successful, this work could identify new, more specific drug targets on GPCRs that lead to better diabetes medicines with fewer side effects.
How similar studies have performed: Allosteric GPCR drugs have progressed into clinical trials before, but combining AI-driven dynamics to study ICL3 and coupling selectivity is a relatively new and emerging approach.
Where this research is happening
Duarte, United States
- Beckman Research Institute/city of Hope — Duarte, United States (Active)
Researchers
- Principal investigator: Vaidehi, Nagarajan — Beckman Research Institute/city of Hope
- Study coordinator: Vaidehi, Nagarajan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.